Popular Trials
Diagnostic Imaging for Pheochromocytoma
Recruiting1 awardPhase 1
Bethesda, Maryland
This trial is testing better methods to detect, locate, and treat pheochromocytomas. These are tumors that usually form in the adrenal glands and can cause high blood pressure. They can be hard to detect with current methods and can lead to severe medical consequences if left undetected.
Popular Filters
Trials for PCC Patients
[18F]FluorThanatrace PET/CT Imaging for Pheochromocytoma and Paraganglioma
Recruiting1 awardPhase < 1
Philadelphia, Pennsylvania
This trial will investigate a PET/CT imaging scan to assess PARP-1 expression in pheochromocytoma/paraganglioma patients before surgery/systemic therapy. It won't influence treatment decisions.
CAR T-cell Therapy
IL13Ralpha2 CAR T Cells for Advanced Skin Cancer
Recruiting1 awardPhase 1
Duarte, California
This trial tests the safety and best dose of modified immune cells for patients with advanced melanoma or other cancers that have spread. The treatment uses the patient's own T cells, which are changed in a lab to better attack cancer cells. The goal is to see if these modified cells can safely and effectively fight the cancer.
Trials for Paraganglioma Patients
[18F]FluorThanatrace PET/CT Imaging for Pheochromocytoma and Paraganglioma
Recruiting1 awardPhase < 1
Philadelphia, Pennsylvania
This trial will investigate a PET/CT imaging scan to assess PARP-1 expression in pheochromocytoma/paraganglioma patients before surgery/systemic therapy. It won't influence treatment decisions.
CAR T-cell Therapy
IL13Ralpha2 CAR T Cells for Advanced Skin Cancer
Recruiting1 awardPhase 1
Duarte, California
This trial tests the safety and best dose of modified immune cells for patients with advanced melanoma or other cancers that have spread. The treatment uses the patient's own T cells, which are changed in a lab to better attack cancer cells. The goal is to see if these modified cells can safely and effectively fight the cancer.
Trials With No Placebo
[18F]FluorThanatrace PET/CT Imaging for Pheochromocytoma and Paraganglioma
Recruiting1 awardPhase < 1
Philadelphia, Pennsylvania
This trial will investigate a PET/CT imaging scan to assess PARP-1 expression in pheochromocytoma/paraganglioma patients before surgery/systemic therapy. It won't influence treatment decisions.
CAR T-cell Therapy
IL13Ralpha2 CAR T Cells for Advanced Skin Cancer
Recruiting1 awardPhase 1
Duarte, California
This trial tests the safety and best dose of modified immune cells for patients with advanced melanoma or other cancers that have spread. The treatment uses the patient's own T cells, which are changed in a lab to better attack cancer cells. The goal is to see if these modified cells can safely and effectively fight the cancer.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.